Fact Sheet

International Headquarters
6901 Preston Road
Plano, TX 75024 USA

Phone
972-309-8000

Fax
972-309-8150

Web Site
www.ans-medical.com

Overview
Advanced Neuromodulation Systems (ANS) is an innovative technology leader in the global neuromodulation market. The company’s mission is to design, develop, manufacture, and market implantable systems to improve the quality of life for people suffering from chronic pain and other disorders of the central nervous system.

Advanced Neuromodulation Systems (ANS) became a division of St. Jude Medical (www.sjm.com) in a merger that was completed in the fourth quarter of 2005. St. Jude Medical’s acquisition of ANS taps the enormous potential of the rapidly growing, billion dollar neuromodulation market and expands St. Jude’s implantable microelectronics technology program.

St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The company has five major focus areas that include: neuromodulation, cardiac rhythm management, atrial fibrillation, cardiac surgery, and cardiology. Headquartered in St. Paul, Minnesota, the company employs approximately 10,000 people worldwide.

For St. Jude Medical investor information, please click here. For more information about ANS, visit About ANS or News Room sections of this site.

Employees
700

Products
Eon^TM  Neurostimulation System  (Rechargeable)
Renew^® Neurostimulation System
Genesis^® Neurostimulation System
GenesisXP^TM - Implantable pulse generator with all the advanced features of Genesis plus extended battery capacity and additional configuration capabilities
Rapid Programmer^® - Palm-sized programming platform designed to work with all ANS SCS systems
Leads - Trial, percutaneous and Lamitrode^® surgical leads offer enhanced stability, multiple configuration options, and ease of implantation